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Abstract
Background This study aimed to compare four non-invasive
intracranial pressure (nICP) methods in a prospective cohort
of hydrocephalus patients whose cerebrospinal fluid dynamics
was investigated using infusion tests involving controllable
test-rise of ICP.
Method Cerebral blood flow velocity (FV), ICP and non-
invasive arterial blood pressure (ABP) were recorded in 53
patients diagnosed for hydrocephalus. Non-invasive ICP
methods were based on: (1) interaction between FV and
ABP using black-box model (nICP_BB); (2) diastolic FV
(nICP_FVd); (3) critical closing pressure (nICP_CrCP); (4)
transcranial Doppler-derived pulsatility index (nICP_PI).
Correlation between rise in ICP (ΔICP) and ΔnICP and aver-
aged correlations for changes in time between ICP and nICP
during infusion test were investigated.
Results From baseline to plateau, all nICP estimators in-
creased significantly. Correlations between ΔICP and ΔnICP
were better represented by nICP_PI and nICP_BB: 0.45 and
0.30 (p<0.05). nICP_FVd and nICP_CrCP presented non-
significant correlations: −0.17 (p=0.21), 0.21 (p=0.13). For
changes in ICP during individual infusion test nICP_PI,
nICP_BB and nICP_FVd presented similar correlations with
ICP: 0.39 ± 0.40, 0.39 ± 0.43 and 0.35 ± 0.41 respectively.
However, nICP_CrCP presented a weaker correlation
(R=0.29±0.24).
Conclusions Out of the four methods, nICP_PI was the one
with best performance for predicting changes in ΔICP during
infusion test, followed by nICP_BB. Unreliable correlations
were shown by nICP_FVd and nICP_CrCP. Changes of ICP
observed during the test were expressed by nICP values with
only moderate correlations.
Keywords Non-invasive ICPmonitoring . Transcranial
Doppler . Cerebral blood flow velocity . CSF infusion test
Introduction
Intracranial pressure (ICP) monitoring is indicated in a wide
range of neurological diseases. However, apart from major
trauma and academic neurosurgical centres, it is not common-
ly part of the clinical management of patients. This scenario is
mainly attributed to the invasiveness of the current methods
(which require insertion of a catheter into the brain) and their
associated risks (infections, brain parenchyma damage and
haemorrhages). Such characteristics limit ICP monitoring in
several clinical conditions in which ICP would be important:
patients with haemorrhagic or ischaemic stroke, mild to mod-
erate traumatic brain injury (TBI), altered mental status or
cognitive/psychological disorders, brain tumours and hydro-
cephalus [7, 8, 11]. As an effort to provide alternatives for ICP
monitoring, some methods have been proposed to measure
and monitor ICP non-invasively (nICP).
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Transcranial Doppler (TCD), for instance, is primarily a
technique for diagnosing various intracranial vascular disor-
ders such as emboli, stenosis or vasospasm [15], but has been
broadly utilised for non-invasive ICP monitoring due to its
ability to detect changes in cerebral blood flow velocity
(FV) derived from ICP variations. TCD has also been used
for non-invasive estimation of cerebral perfusion pressure
(CPP), based on some parameters derived from FV, such as
diastolic flow velocity (FVd) [6] and critical closing pressure
(CrCP) [17]. Considering the assumption that CPP equals the
difference of arterial blood pressure (ABP) and ICP, nICP can
be estimated as nICP=ABP – nCPP.
Infusion test is a diagnostic modality that enables assess-
ment of the cerebrospinal fluid (CSF) dynamics and the com-
pensatory ability of the cranial-spinal fluid system in patients
diagnosed with hydrocephalus [18]. The principle of this test
is based on a constant infusion rate of artificial CSF into any
accessible CSF compartment, which produces a gradual and
uncompensated increase in ICP [10]. Our objective in this
study was to compare the estimation performances of four
TCD-based nICPmethods in cohort of hydrocephalus patients
whose CSF dynamics were investigated using infusion tests
involving controllable test-rise of ICP.
Materials and methods
Patients
We retrospectively analysed data collected during the period
of 1994–1998 and 2006 at Addenbrooke’s Hospital, Cam-
bridge, United Kingdom. The population consisted of 53 pa-
tients who undertook an infusion test in order to investigate
CSF disturbances. Measurements included ICP, ABP and FV
in middle cerebral artery (MCA). The median age of the pa-
tients was 55 years [interquartile range (IQR), 66–38 years; 31
men, 22 women].
Infusion test
An infusion test is a computerised method involving cerebro-
spinal infusion of artificial CSF (normal saline or Hartman’s
solution) into the subarachnoid space, based on the traditional
constant rate infusion test described by Katzman and Hussey
[10]. For this purpose, one spinal needle (18 G, 3.50 in.) is
inserted between the lumbar L3/L4 or L4/L5 vertebrae, and it
is used for both pressure measurements and fluid infusion.
This needle is connected to a pressure transducer via a stiff
saline-filled tube and to an infusion device (Alaris® GH Plus
Syringe Pump; Carefusion, Basingstoke, UK) with a 50-mL
syringe (BD, Oxford, UK), mounted on a trolley containing a
pressure monitor (Simonsen and Will, Sidcup, England) con-
nected to a computer [5]. The threshold of the opening
pressure is 13 mmHg and the infusion rate is 1 mL/min when
the pressure is higher than the threshold. Conversely, the in-
fusion rate is 1.5 mL/min when the pressure is lower than the
threshold. The start of infusion is initiated after baseline re-
cording (10 min), whereas the end of the infusion is signalled
by the achievement of a steady-state ICP plateau. If ICP rises
above 40 mmHg, the infusion needs to be discontinued to
avoid excessive elevation of the pressure above the safe clin-
ical limits [18]. After cessation of the infusion, ICP is contin-
uously recorded until it decreases to a steady baseline level
[5].
Data acquisition
The ICP measurements were made with the patient placed
in a lateral position (left or right), considering the foramen
of Monro as the zero calibration reference. TCD ultrasonog-
raphy (Neuroguard; Medasonics, Fremont, CA, USA) was
used for monitoring of blood FV in the MCA, through a 2-
MHz probe fixed on the cranium by using a commercially
available headband. ABP was recorded non-invasively by
using a Finapres® finger cuff (Ohmeda, Englewood, CO,
USA) positioned at the level of the heart. Analogue outputs
of ICP and ABP from the pressure monitors and the TCD
monitor were connected to an analogue-to-digital converter
(DT2814; Data Translation, Marlboro, CA, USA) fitted into
an IBM-compatible laptop computer (Amstrad ALT 386
SX; Amstrad, Brentwood, UK). Data were sampled
(50 Hz), digitised and stored on the hard disk using software
for waveform recording (WREC; W. Zabolotny, Warsaw
University of Technology, Warsaw, Poland). The recorded
signals were then analysed using ICM+ software (Cam-
bridge Enterprise, http://www.neurosurg.cam.ac.uk/
icmplus). Informed consent was obtained from all
individual participants included in the study (or their next
of kin) for the use of collected data for research purposes.
The infusion test is a routine clinical investigation in the
Hydrocephalus Clinic , Addenbrooke’s Hospital ,
Cambridge, with no ethical approval required. The data
were analysed anonymously as a part of a clinical audit.
Non-invasive ICP methods
The four methods used for nICP estimation in this study were:
1. Schmidt et al. [14] Bblack-box^ (BB) model (nICP_BB):
nICP is obtained from a mathematical Bblack-box^model
based on the presumed transformation between ABP and
ICP waveforms. Coefficients of these transformations are
derived from the database of real ABP and ICP record-
ings. Similar linear transformation is built, using the same
database between FVand ABP. Then, the model assumes
a linear relationship between ABP and FV and ABP to
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ICP transformations. Multiple regression coefficients are
calculated. Finally, for each prospective study, ICP is cal-
culated using ABP to ICP transformation, formed from
ABP to FV transformation transposed using precalculated
regression coefficients. Non-invasive ICP estimation
using this method was performed using a plugin devel-
oped for ICM+ software.
2. Czosnyka et al. [6] (nICP_FVd): for this method, based on
the diastolic flow velocity for the estimation of nCPP, nICP
was calculated as the difference between ABP and nCPP
(nICP=ABP - nCPP). The equation for nCPP estimation is:
nCPP ¼ ABP  FVd
FVm
þ 14 ð1Þ
FVm and FVd represent mean and diastolic flow velocity,
respectively.
3. Varsos et al. [17] (nICP_CrCP): this method also calcu-
lates nICP based on nCPP, in this case specifically using
the concept of critical closing pressure (CrCP). The equa-
tion for nCPP estimation is:
nCPP ¼ ABP  0:734− 0:266ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ










CVR represents cerebral vascular resistance, Ca de-
notes arterial compliance of the cerebral bed and HR
expresses heart rate (beats/s), with ABP and FV as the
required measurements. Constant coefficients (0.734,
0.266, 7.026) are derived from analysis of database of
232 TBI retrospective cases [17].
4. nICP_PI: nICP estimation based on TCD-derived
pulsatility index was based on the linear regression
among known values of ICP and pulsatility index (PI)
from a population cohort of 292 TBI patients. The regres-
sion equation was based on data analysed by Budohoski
et al. [2] and given by:




FVs, FVd and FVm represent systolic, diastolic and mean
flow velocity.
Statistical analysis
Statistical analysis of the data was conducted with OriginPro
statistical software (version 8; OriginLab, Northampton, MA,
USA). Data were tested for normal distribution using Shapiro-
Wilk test. The analysis included Spearman correlations be-
tween mean ΔICP and ΔnICP and averaged correlations for
variations of nICP across time during ICP increase. The Δ
value (magnitude) was considered the difference between pla-
teau and baseline mean values in each recording during infu-
sion. R represents the Spearman correlation coefficient, with
the level of significance set at 0.05. The Bland-Altman meth-
od was used to determine the agreement between measured
ICP and the different nICP methods, with their respective
95%CI for prediction of ICP and bias for baseline and plateau
periods. The confidence interval represents the range of values
around the bias (difference between mean values of nICP and
ICP), in which data can be found with a significance level of
0.05. In addition, Mann–Whitney test was used to assess
whether nICP samples originate from the same distribution
as ICP for both baseline and plateau phases of infusion test.
Wilcoxon test was applied to assess whether there was any
significant difference between baseline and plateau phases for
each estimator and calculated variables.
Results
Table 1 presents all estimated physiological variables used for
nICP estimations, at baseline and plateau phases, and their Δ
correlations with ΔICP. Table 2 presents comparisons among
non-invasive methods adopted in this study.
Median values of ICP and nICP are presented with their
respective interquartile ranges (IQRs) in mmHg. Mann–Whit-
ney test revealed significantly different distributions between
all nICP estimators and ICP for baseline; for plateau phase
only nICP_BB and nICP_PI presented such differences.
Wilcoxon test revealed significantly different distributions be-
tween baseline and plateau nICPs and ICP.
Regarding confidence intervals (Bias ±95%CI), nICP_BB
showed 15.33 ± 4.46 mmHg; nICP_FVd showed 25.19
± 11.90 mmHg; nICP_CrCP showed 15.09± 11.12 mmHg
and nICP_PI showed 10.58 ±8.91 mmHg. During plateau
every method presented increased CI: 19.21±−7.35 mmHg
for nICP_BB; 29.97 ±1.66 mmHg for nICP_FVd; 17.80±
−2.53 mmHg for nICP_CrCP and 19.07±−6.18 mmHg for
nICP_PI.
Correlations between ΔICP and ΔnICP were better repre-
sented by nICP_PI and nICP_BB, with 0.45 (p=0.0007) and
R=0.30 (p=0.03), respectively. The other methods presented
inferior and non-significant correlations: −0.17 (p= 0.21),
0.21 (p=0.13) for ICPn_FVd, nICP_CrCP, respectively.
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Regarding variations of nICP in time domain during
ICP increase nICP_PI, nICP_BB and nICP_FVd present-
ed similar averaged correlations, 0.39 ± 0.40, 0.39 ± 0.43
and 0.35 ± 0.41, respectively. However, nICP_CrCP pre-
sented a smaller correlation (R= 0.29 ± 0.24). To demon-
strate such variations and correlation between nICP and
ICP in time, examples of a good and a poor recording of
nICP with the four investigated methods when ICP
changed considerably during the infusion test are showed
in Figs. 1 and 2, respectively.
Discussion
TCD has been used to estimate nICP in several conditions;
however, their relative accuracy varies between different types
of intracranial hypertension: vasogenic, CSF circulatory or
secondary to brain volumetric changes (oedema, contusion,
haematoma, etc.). Schmidt et al. [14] reported a CI for predic-
tion of 12.8 mmHg, and Cardim et al. [3] a CI of 9.94 mmHg
for nICP_BB. Kashif et al. [9], also using a model based on
ABP and FV, reported 15 mmHg (standard deviation of error
(SDE) of 7.6 mmHg). Using TCD-derived PI, Bellner et al. [1]
and Cardim et al. [3] reported a 95 % CI for prediction of
4.2 mmHg and 9.62 mmHg, respectively. Non-invasive ICP
methods based on the concepts of FVd and CrCP were also
assessed and presented with CI of 14.62 mmHg and
9.19 mmHg, respectively [3]. For the moment, these confi-
dence intervals have mainly been described for traumatic
brain injury patients, with the exception of PI, which reflected
a cohort of patients with several intracranial disorders [1].
The assessment of TCD-based nICP estimators during
infusion tests revealed a limited accuracy of assessment
ICP non-invasively and discrepancy in estimation of ICP.
Of the four studied estimators, relative changes in mean
ICP were better associated with estimated ICP using only
two methods. Best scenario was obtained with the method
based on TCD pulsatility index, followed by the mathe-
matical black-box model, whereas the other methods did
not present satisfactory correlation with measured ICP.
Table 1 Median values (IQR), 95 % CI for prediction of ICP and bias
(in mmHg) are described for baseline and plateau phases. Spearman
correlation between ΔICP vs ΔnICP and averaged correlation across
time during ICP increase (n = 53). At the 0.05 level, baseline and
plateau distributions of nICPs and ICP are significantly different
Method Baseline Plateau R R
Median (IQR) 95 % CI Bias Median (IQR) 95 % CI Bias (ΔICP vs ΔnICP) (time domain)
nICP_BB 10.76 (15.08-7.30)a 15.33 4.46b 14.86 (20.1-11.26)a 19.21 −7.35b 0.30c 0.39 ± 0.43
nICP_FVd 16.97 (22.56-11.64)a 25.19 11.90b 21.74 (32.85-14.15) 29.97 1.66 −0.17 0.35 ± 0.41
nICP_CrCP 18.34 (20.38-14.89)a 15.09 11.12b 19.65 (23.80-16.92) 17.80 −2.53b 0.21 0.29 ± 0.24
nICP_PI 16.57 (17.46-16.06)a 10.58 8.91b 17.12 (17.73-16.40)a 19.07 −6.18b 0.45c 0.39 ± 0.40
ICP 7.74 (11.06-2.95) - - 22.13 (29.77-16.41) - - - -
a At the 0.05 level, distributions between nICP and ICP are significantly different
b The population mean is significantly different with the test mean (zero)
c Spearman correlation coefficient is significant at the 0.05 level
Table 2 Median (IQR) values for
all physiological variables esti-
mated during baseline and plateau
phases, with their respective
Δcorrelations with ΔICP (R)
Variable Baseline Plateau p value R (ΔICP) R (ΔABP)
ICP 7.77 (11.06-2.95) 22.13 (29.77-16.41)a 2.2 × 10−16 - 0.1
ABP 89.68 (101.5-78.23) 96.08 (121–87.07)a 5.6 × 10−6 0.11 -
HR 67.86 (77.96-61.98) 70.12 (79–60.83) 0.39 0.15 0.28b
CPP 82 (98.67-73.27) 79.40 (96.53-67.14)a 7.9 × 10−4 −0.38b 0.82b
FV 54.2 (66.27-42.47) 49.76 (61.92-39.07)a 8.4 × 10−6 0.14 −0.20
FVs 81.61 (101.6-66.76) 79.97(98.65-63.35) 0.07 −0.03 −0.21
FVd 33.17 (43.86-27.32) 31.93 (40.61-23.57)
a 1.4 × 10−6 −0.22 0.21
PI 0.84 (1.05-0.76) 0.99 (1.13-0.83)a 1.1 × 10−9 0.45b −0.04
CVR 1.64 (1.95-1.22) 1.55 (2.05-1.13) 0.56 −0.21 0.62b
a At the 0.05 level, distributions between baseline and plateau are significantly different
b Spearman correlation coefficient is significant at the 0.05 level
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Considering trends of measured ICP in time, all nICP
methods presented better performance and overall corre-
lations were more balanced among them.
Considering absolute values of ICP, analysis showed
significantly different distributions between all nICP
methods and ICP for baseline, whereas during the plateau
phase nICP_FVd and nICP_CrCP had the same distribu-
tions as ICP. This indicates that, with exception of these
cases, the nICP estimators were not able to accurately pre-
dict the absolute measure of ICP during these phases of the
infusion test.
Nevertheless, all paired comparisons between estimators
for baseline and plateau showed significant differences,
demonstrating that infusion test did produce a significant
increase in nICP for every estimator. Although significant
within the same method, these differences were dispropor-
tional when comparing measured ICP and nICP estima-
tions. Such disproportion was reflected in the confidence
intervals for prediction found for baseline and plateau
phases. In regards to bias, a non-significant difference be-
tween non-invasive and invasive methods is desirable,
which means that both methods are not different in ren-
dering mean ICP values. In this case, with exception of
nICP_FVd during plateau phase, all estimators presented
significant biases.
Regarding correlations between ΔICP and ΔnICP,
such results demonstrate the ability of the nICP methods
to detect the magnitude of changes in measured ICP.
Even though considered moderate correlations, nICP_PI
and nICP_BB were the only estimators to present sig-
nificant levels. For detection of trends in time, which
does not consider ICP as a numeric value but the be-
haviour of the methods during an ICP increase, the
methods also displayed moderate averaged correlations.
They showed better agreement for nICP_PI, nICP_BB
and nICP_FVd , and a weaker cor re la t ion for
nICP_CrCP. Figures 1 and 2, respectively, represent
good and poor examples of correlations in time among
ICP and nICP estimators.
As observed, nICP estimation differed mostly in terms of
prediction of absolute values of ICP during infusion tests and
to a lesser extent in terms of detection of dynamic changes.
Fig. 1 Example of good recording of nICP with four investigated
methods when ICP changed considerably during the infusion test. a
ICP; b nICP_BB; c nICP_FVd; d nICP_CrCP; e nICP_PI. R represents
correlation coefficient between ICP and nICP (R= 0.93 for nICP_BB;
R= 0.78 for nICP_FVd; R= 0.63 for nICP_CrCP; R= 0.81 for nICP_PI)
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Different nICP accuracies may be explained by each method’s
specific characteristics. The nICP_BB method reflects ABP
waveform being constantly modified by TCD characteristics,
and then is mostly susceptible to changes of vasogenic origin
(such as CVR) and consequently cerebral blood flow. The
nICP_FVd method (Eq. 1) is mostly modulated by the factor
FVd/FVm and ABP. The nICP_CrCPmethod (Eq. 2) is mod-
ulated by changes in CVR and also byABP. For nICP_PI, any
changes in the components of flow velocity (FVm, FVs and
FVd) are reflected in the PI calculation and consequently in
the nICP estimation.
The nature of ICP elevation during infusion test is
attributed to an increase in CSF circulation due to a
direct addition of volume into the CSF space. TCD
ultrasonography, however, is a technique mainly capable
of detecting cerebrovascular changes in the arterial bed
[15] (in our case, specifically the MCA). Thus, theoret-
ically, it would be expected that changes in ICP esti-
mated with TCD-based methods would present better
accuracy if they were of vasogenic origin, rather than
caused by var ia t ions of pressure in the CSF
compartment.
This can be exemplified by the fact that in specific cases
where changes of ICP related to vasogenic fluctuations (pla-
teau waves, B waves) overlapped the rise related to CSF in-
fusion, the time-trend correlation between real and estimated
ICP seemed to be remarkably better (as seen in Fig. 3), even
with reliable replications of vasogenic waves patterns.
The way fluctuations in CSF circulation are transmitted
to cerebral arterial bed might help understand the low
accuracies presented by TCD methods during infusion
test. In these circumstances, the rise in ICP originated
from increased CSF circulation has direct and indirect
influences on cerebral haemodynamics. The direct influ-
ence is represented by changes in CPP, altered directly by
ICP. On the other hand, ICP has an indirect effect on
cerebral haemodynamics, via changes in systemic
haemodynamics. The changes in ABP observed during
Fig. 2 Example of poor recording of nICP with four investigated
methods when ICP changed considerably during the infusion test. a
ICP; b nICP_BB; c nICP_FVd; d nICP_CrCP; e nICP_PI. R represents
correlation coefficient between ICP and nICP (R= 0.29 for nICP_BB;
R = −0.31 for nICP_FVd; R = −0.35 for nICP_CrCP; R = 0.32 for
nICP_PI)
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infusion tests are associated with an early Cushing re-
sponse [13], in which rising ICP yields an increase in
ABP. Therefore, transmission of fluctuations in CSF cir-
culation to the cerebral arterial bed are primarily given by
a decrease in CPP and secondarily by an increase in ABP.
In regard to haemodynamic and TCD-derived cere-
brovascular variables used for the method’s estimations
(ABP, HR, FV, FVs, FVd, PI and CVR), HR, FVs and
CVR did not differ between plateau and baseline
phases. Within the variables which presented significant
difference, only changes in CPP and PI (ΔCPP and ΔPI)
were significantly correlated with changes in ICP. This
finding is in agreement with results obtained by Bellner
et al. [1], in which PI was strongly correlated with
changes in ICP. In our case, however, PI presented only
a moderate correlation with ICP, and was mainly mod-
ulated by FVd, as FVs did not present significant
changes between baseline and plateau.
In this study, changes in ABP were significantly correlated
to changes in CVR. This signifies that although such changes
were not significant between baseline and plateau phases, this
secondary increase in ABP produced by an early Cushing
response caused minor vasogenic changes in cerebral
haemodynamics [13]. This could have contributed to the bet-
ter accuracy in cases which patients presented changes in ICP
of vasogenic origin (Fig. 3).
Consequently, the low accuracy for prediction of ICP
observed for TCD-based methods might be related to the
nature of ICP elevation during infusion tests. Although
increased CSF circulation is able to produce secondary
changes on cerebral haemodynamics, this might not be
the ideal manner to produce global changes of vasogenic
origin that could be detected more accurately by TCD.
Therefore, under these conditions, TCD cannot be consid-
ered a suitable technique for nICP estimation in condi-
tions of increased CSF circulation.
In conclusion, changes of ICP observed during the test
were expressed by nICP values with only moderate correla-
tions. Vasogenic components of ICP seemed to be easier to
estimate with TCD, than component related to increased CSF
circulation. In this context, out of the four methods assessed,
nICP_PI was the one with best performance for predicting
changes in ΔICP during infusion test, followed by nICP_BB.
Methods based on FVd and CrCP showed unreliable
correlations.
Limitations
An intrinsic limitation of this study is that it considers analysis
of retrospective data, collected at two different time points
(1994–1998 and 2006). The majority of data was collected
in the first period (n=39, 73.6 %); nevertheless, the method-
ology and equipment used did not differ between the collec-
tion points. However analysis of retrospective data may evi-
dence downsides of the study design, such material is unique
and contains important information about the cerebrovascular
dynamics of normal pressure hydrocephalus (NPH) patients
during CSF infusion tests, which may be useful in different
scenarios and applications.
A well-known limitation in studies approaching cerebral
blood flow velocity measured with TCD is the inter- and
intra-operator variability, as demonstrated by McMahon et
al. [12]. Here, we attempted to minimise it by allowing only
two experienced operators (M.C. and Z.C.) to collect the data.
Fig. 3 Example of vasogenic waves during infusion test. a Shadowed area represents a plateau wave of ICP. b Shadowed area represents B waves of
ICP. It is possible to observe that at least for trends in time, there were good concordance between ICP and nICP methods
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It is then assumed for this study that such variability was
minimal.
A potential limiting factor to this study could be the
non-invasive measurement of ABP. Although the re-
sponse bandwidth obtained with Finapres® is adequate
to register the ABP waveform with reliable accuracy,
the supporting applications in which waveform-
dependent indices are extracted [4] (such as in nICP_BB
method), relative accuracy in terms of mean values of
ABP did not show to be very precise. In a previous
study, Stokes et al. [16] performed a comparison of
invasive and non-invasive ABP measurements (specifi-
cally using Ohmeda Finapres® 2300), and found an
inter-individual variability in absolute pressure readings.
In our case, this could promote a misestimation for
nICP_FVd and nICP_CrCP, which present ABP as mul-
tiplier in the formula.
Another limiting factor could be the origin of the methods
used for nICP estimations, as all of them were derived from
cohorts of traumatic brain injury patients. Different physiolog-
ical mechanisms leading to ICP fluctuations in TBI and hy-
drocephalus might play a significant role in the way ICP was
estimated.
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Comment
Cardim and colleagues retrospectively analysed four different non-
invasive methods to assess ICP during CSF infusion test in 53 patients.
Even though this is a retrospective study with the well-known limitations
of this study design and two of the four methods assessed demonstrated
unreliable correlations to the real ICP, the study is worth being published
in my opinion, since it would be of high importance if a way of non-
invasively assessing ICP could be found. Hopefully, this paper encour-
ages even more study groups to deal with this challenge.
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Giessen, Germany
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